How are they administered
Key Takeaways The FDA repeated its decision that the shortage of the blockbuster diabetes and weight loss drug tirzepatide is over The announcement means that compounding pharmacies must stop producing the drug by March 19 Other shortages of popular GLP-1 medications remain THURSDAY, Dec
Start your intake Why Patients Transition Between GLP-1 Medications Common reasons for switching include gastrointestinal intolerance (nausea, vomiting, constipation), inadequate weight loss response, medication availability, cost barriers, or treatment goals shifting from weight loss to diabetes management
Medical Teams: Beluga Health: A trusted team of nationwide medical professionals led by Dr
Yes, Stykus platform allows for a chronological view, showcasing your transformation over multiple sessions